© 2025 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Incunabulum LLC.
Sue Dehnam
Rescheduling’s Fine Print: DEA Becomes Mandatory Middleman
The DEA isn’t stepping back; it’s stepping in. While the industry celebrates the end of 280E, the fine print of the new Schedule III order reveals a mandatory federal middleman, undisclosed fees, and a legal “prescription” trap that could leave dispensaries in limbo. Here is what the rescheduling order actually means for your bottom line.
ASA Launches Navarro Family Organ Transplant Resource Center
ASA launches the Navarro Family Organ Transplant Resource Center to provide tools and advocacy for medical cannabis patients facing transplant discrimination.
WM Technology to Voluntarily Delist from Nasdaq
Following a series of SEC penalties, executive shifts, and a failed bid to go private, Weedmaps’ parent company prepares to transition to the OTC Markets.
Inside the GTI-RYTHM Brand Licensing Loop
GTI’s new $70 million annual payment to RYTHM is the latest twist in a longer story of brand transfers, debt, and overlapping leadership.
Vireo Growth Closes Schwazze Asset Deal in Colorado and New Mexico
The transferred assets include 24 dispensaries in Colorado, 21 dispensaries in New Mexico, and one manufacturing facility in each state.
CBD and CBG Show Promise against Fatty Liver Disease in New Study
A new study from Hebrew University of Jerusalem suggests CBD and CBG may help combat fatty liver disease by reducing liver fat, improving energy regulation, and restoring cellular cleanup functions.
Even with Auto-Enrollment, Cannabis Workers Reject 401(k)s
Only about 39 percent of cannabis workers participate in workplace retirement plans — about 18 points below the U.S. rate — and even auto-enrollment isn’t fixing the gap. A new cannabis-only report analyzing 140 plans across 420+ entities found opt-out rates near one in three among automatically enrolled employees, despite sophisticated plan design and meaningful employer contributions. The problem is less about plan features and more about worker realities.
How to Measure the Real ROI of Cannabis PR
Public relations plays an outsized role in cannabis marketing — but impressions alone don’t prove value. This feature breaks down how to measure PR ROI, connect earned media to revenue and market share, and build attribution systems executives and CFOs actually trust.
Cannabis Rescheduling FAQ: Your Questions Answered
What cannabis rescheduling to Schedule III really means, how the process works, and why it matters for businesses and patients.
Cannabis Rescheduling Explained: What Moving Marijuana to Schedule III Would Change
Rescheduling marijuana from Schedule I to Schedule III would not legalize cannabis — but it could fundamentally alter how the federal government treats the plant. From tax policy and medical research to regulatory oversight, here’s what cannabis rescheduling actually means, how the process works, and why it matters to businesses, patients, and policymakers.